Q3 FY26 results: 3rd interim dividend INR 3.5, record date Feb 5
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Lal PathLabs reported Q3 FY26 consolidated revenue from operations of INR 6,598 million, up 10.6% year-on-year. Nine-month profit after tax rose to INR 3,776 million from INR 3,367 million earlier year. Board declared a 3rd interim dividend of INR 3.5 per share for FY26 with record date February 5, 2026. The company also allotted 4,000 equity shares under ESOP 2010. Q3 results include a one-time exceptional charge of INR 301 million for Labour Codes impact.
Shareholders eligible for INR 3.5/share dividend on record date Feb 5, 2026. 9M profit up around 12% YoY. One-time Labour Codes charge of INR 301 million weighed on Q3 earnings.